Department of Radiology, Key laboratory of Carcinogenesis and Translational Research Ministry of Education, Peking University School of Oncology, Beijing Cancer Hospital & Institute, 52 Fu Cheng Road, Hai Dian District, Beijing 100142, China.
Eur J Radiol. 2011 Mar;77(3):473-7. doi: 10.1016/j.ejrad.2009.09.016. Epub 2009 Oct 22.
To assess the extent to which pretreatment imaging of lymph nodes by computed tomography (CT) predicts survival of patients with rectal cancer.
We retrospectively analyzed 70 patients with rectal cancer, who had pretreatment CT and curative surgery between December 1999 and October 2003. These patients were followed until December 2007, ensuring minimal follow-up time of 49 months. Two radiologists who reviewed the CT images on workstations had no prior access to clinical and treatment information regarding the selected patients. The parameters assessed for survival analysis were as follows: patient age, sex, CEA and CA199 level, preoperational therapy, tumor location, serosal invasion, largest diameters and numbers of lymph nodes on pretreatment CT. Kaplan-Meier survival curves, the log-rank test, and the multivariate Cox proportional hazards model were used to evaluate the prognostic value of the parameters.
Using pretreatment CT as prognostic tool, we found that both size and number of lymph nodes correlated with the overall survival of patients with rectal cancer. The data proved that a diameter smaller than 8mm for the largest lymph node was correlated with prolonged survival (P < 0.001). Meanwhile, patients with more than 4 lymph nodes had a significantly worse disease-specific survival (P = 0.042). Both parameters are independent prognostic factors (hazard ratio 4.910 and 3.563) and could predict the overall survival of rectal cancer patients.
The lymph node size and number, as determined by pretreatment CT, is an important clinical prognostic factor in patients with rectal cancer. The pretreatment CT findings could be used to predict survival and plan appropriate therapies.
评估计算机断层扫描(CT)对淋巴结的预处理成像预测直肠癌患者生存的程度。
我们回顾性分析了 1999 年 12 月至 2003 年 10 月间 70 例接受直肠癌预处理 CT 和根治性手术的患者。这些患者随访至 2007 年 12 月,确保最小随访时间为 49 个月。两位在工作站上查看 CT 图像的放射科医生事先没有接触过选择患者的临床和治疗信息。用于生存分析的参数如下:患者年龄、性别、CEA 和 CA199 水平、术前治疗、肿瘤位置、浆膜侵犯、预处理 CT 上的最大直径和淋巴结数量。采用 Kaplan-Meier 生存曲线、对数秩检验和多变量 Cox 比例风险模型评估参数的预后价值。
使用预处理 CT 作为预后工具,我们发现淋巴结的大小和数量均与直肠癌患者的总体生存率相关。数据表明,最大淋巴结直径小于 8mm 与生存时间延长相关(P < 0.001)。同时,淋巴结大于 4 个的患者疾病特异性生存率明显较差(P = 0.042)。这两个参数均为独立的预后因素(风险比 4.910 和 3.563),可预测直肠癌患者的总体生存率。
通过预处理 CT 确定的淋巴结大小和数量是直肠癌患者重要的临床预后因素。预处理 CT 结果可用于预测生存并制定适当的治疗计划。